Platelet-Rich Fibrin Dressing in the Management of Free Gingival Graft

July 16, 2019 updated by: Damascus University

Evaluation of the Usage of Platelet-Rich Fibrin Dressing in the Management of Free Gingival Graft and Donor Site Palatal Wound

Evaluation of two dressing materials; a Platelet-Rich Fibrin (PRF) dressing and a non-eugenol-based (Coe-Pak™) dressing in the management of free gingival graft and donor site palatal wound.

Study Overview

Detailed Description

Evaluation of the usage of platelet-rich fibrin dressing in the management of free gingival graft and donor site palatal wound by evaluation of pain score, healing tissue in both donor and receiving sites, coverage of gingival recession, and the gain of attached gingiva.

A total of 20 subjects will be invited to participate in this study from the patients seeking treatment at the Department of Periodontology, Faculty of Dentistry, Damascus University.

The study has been approved by the investigator's local Review Board. Subjects will be recruited according to specific inclusion criteria. After completion of medical and dental history questionnaires, patients will sign a consent form after being advised about the nature of the study.

Patients will be allocated into two groups (10 patients each). A Platelet-Rich Fibrin (PRF) dressing will be used in both donor and receiving sites in the test group, while a non-eugenol-based (Coe-Pak™) dressing will be used in both donor and receiving sites in the control group .

Donor site working time, bleeding (BLE), colour match (CM), pain and re-epithelization (EP) will be evaluated.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients of Syrian descent.
  • Systemically healthy.
  • Attached gingival width ≤ 2 mm.
  • Presence of type II (Miller Classification) of gingival recession.

Exclusion Criteria:

  • Smoking.
  • Pregnancy or lactating.
  • Presence of any systematic diseases can affect the periodontal surgery.
  • Subjects with significant moderate to severe periodontal disease.
  • Patients under orthodontic treatment
  • Presence of restorative materials (e.g. crown)
  • Subjects have failed to maintain good plaque control.
  • Subjects having previous surgical treatment for covering the recession in the chosen area.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A Platelet-Rich Fibrin dressing
A Platelet-Rich Fibrin dressing (PRF) will be used in both donor and receiving sites after a free gingival graft.
A free gingival graft will be used for the treatment of gingival recession
A Platelet-Rich Fibrin dressing (PRF) will be applied in both donor and receiving sites after the free gingival graft.
Experimental: A non-eugenol-based dressing
A non-eugenol-based dressing (Coe-Pak™) will be used in both donor and receiving sites after a free gingival graft.
A free gingival graft will be used for the treatment of gingival recession
A non-eugenol-based dressing (Coe-Pak™) will be applied in both donor and receiving sites after the free gingival graft.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The pain score using the visual analogue scale (VAS)
Time Frame: The Pain score will be evaluated twice. At T1 (after 2 days of surgery) and T2 (after 7 days of surgery).
This variable is going to be measured by an visual analogue scale (VAS). The VAS pain scores ranges between 0 to10. (0: no pain, 1: minimal pain, 10: severe pain).
The Pain score will be evaluated twice. At T1 (after 2 days of surgery) and T2 (after 7 days of surgery).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healing index for free gingival graft
Time Frame: The healing index will be evaluated twice. At T1 (after one week of surgery) and T2 (after one month of surgery)..
The healing index for free gingival graft is an ordinal score: very poor, poor, good, very good and excellent.
The healing index will be evaluated twice. At T1 (after one week of surgery) and T2 (after one month of surgery)..
The complete re-epithelialization of the palatal wound
Time Frame: The measurements will be performed at T1 (after 1 week measurement), T2 (after 2 weeks measurement), T3 (after 3 weeks measurement), and T4 (after 4 weeks measurement).
This variable is going to be measured using the peroxide test. Scores are yes or no for showing bubbles.
The measurements will be performed at T1 (after 1 week measurement), T2 (after 2 weeks measurement), T3 (after 3 weeks measurement), and T4 (after 4 weeks measurement).
Changes in gingival recession
Time Frame: The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).
Miller Class II of Gingival recession is measured from the cemento-enamel junction to the gingival margin of the recessed tissues.
The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).
Match color of the palatal wound
Time Frame: The measurement will be performed at T1 (after 1 week measurement) and T2 (after 1 month measurement).
VAS scores (between 0 and 10. 0: no CM, 10: excellent CM) in comparison with adjacent and contralateral palatal mucosa.
The measurement will be performed at T1 (after 1 week measurement) and T2 (after 1 month measurement).
Attached gingival width
Time Frame: The measurement will be performed at T0 (baseline measurement) and at T1 (after 3 months measurement).
Measured from the Mucogingival junction to the gingival Groove.
The measurement will be performed at T0 (baseline measurement) and at T1 (after 3 months measurement).
Plaque index
Time Frame: The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).
Score: none, simple, middle, severe.
The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).
Gingival Index
Time Frame: The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).
Score: none, simple, middle. Severe.
The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).
Bleeding on probing Index
Time Frame: The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).
Score: bleeding, none bleeding.
The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).
Pocket Probing Depth
Time Frame: The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).
Score: normal, simple, middle, severe.
The measurement will be performed at T0 (baseline measurement) and at T1 (at three months exactly post-operatively measurement).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ali Abou Sulaiman, PhD., Department of Orthodontics, Faculty of Dentistry, Damascus University, Damascus, Syria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

September 1, 2018

Study Completion (Actual)

February 1, 2019

Study Registration Dates

First Submitted

July 2, 2018

First Submitted That Met QC Criteria

July 16, 2018

First Posted (Actual)

July 17, 2018

Study Record Updates

Last Update Posted (Actual)

July 18, 2019

Last Update Submitted That Met QC Criteria

July 16, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The Individual participant data will be only available for the researchers in the department of Periodontics, Damascus University

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingival Recession

Clinical Trials on A free gingival graft

Subscribe